secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2022-01-24T23:59:59+00:00
Accession:  0001193125-22-016015
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Reneo appoints Paul Hoelscher to board and audit committee chair; two directors exit
--------------------------------------------------------------------------------

- Paul Hoelscher appointed Class I director and Audit Committee Chair, effective Jan 20, 2022.
- Hoelscher receives $40k annual cash retainer plus $15k as Audit Committee Chair, and option for 35,000 shares vesting over 3 years.
- Lon Cardon will not stand for re-election at 2022 annual meeting due to new role at Jackson Laboratory.
- Kenneth Harrison resigned from board effective Jan 20 to focus on other endeavors; no disputes involved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312522016015/0001193125-22-016015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312522016015/d299391d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-016015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer